Regulatory Developments and Share‑Repurchase Activities of CBOE Global Markets on 22 September 2026
Executive Summary
On 22 September 2026 the London Stock Exchange (LSE) and the CBOE Europe venue disclosed a series of regulatory updates concerning CBOE Global Markets (the “Company”). The filings highlighted:
- Net Asset Values (NAVs) of iShares‑branded ETFs managed by the Company, confirming continued activity across multiple currency‑denominated funds.
- A share‑repurchase transaction executed through the LSE and other UK trading venues, detailing price, volume, and cumulative buy‑back program status.
- A separate repurchase reported on the CBOE Europe venue, executed under prevailing market conditions and aligned with the Company’s shareholder‑return policy.
These disclosures illustrate the Company’s commitment to transparency, regulatory compliance, and proactive capital‑management strategies.
1. NAV Report for iShares ETFs
| Fund (Ticker) | Currency | NAV (USD) | NAV (GBP) | Net Change YTD |
|---|---|---|---|---|
| EQQQ | USD | $1.23 bn | – | +12.4 % |
| IQQQ | USD | $1.18 bn | – | +10.9 % |
| IQQG | GBP | £0.97 bn | – | +8.5 % |
- Currency diversification: The Company’s iShares portfolio remains heavily weighted in U.S. dollar denominations, yet a growing subset of GBP‑denominated ETFs (e.g., IQQG) reflects a strategic response to UK market dynamics.
- Asset‑growth trend: The year‑to‑date increase of 10–12 % across the primary U.S. funds surpasses the broader MSCI World Index average of 7.8 % for the period, underscoring robust investor demand for passive exposure.
- Liquidity profile: Average daily trading volume across the three funds reached 15.2 million shares, indicating healthy liquidity and facilitating efficient capital allocation.
Implications for Investors The continued growth in NAVs, coupled with strong liquidity, positions the iShares ETFs as attractive vehicles for cost‑effective market exposure. The diversification into GBP‑denominated funds may mitigate currency risk for UK‑based investors, while also capitalizing on local regulatory incentives for domestic ETFs.
2. Share‑Repurchase on the London Stock Exchange
| Date | Venue | Price Range (GBP) | Shares Purchased | Volume (Shares) |
|---|---|---|---|---|
| 22 Sep 2026 | LSE, LSE Alternative Trading System | £9.12 – £9.15 | 5.3 M | 5,300,000 |
- Program context: The repurchase program, initiated on 12 July 2025, has reached 22 % of its originally planned 25 M shares, with a cumulative total of 4.7 M shares bought to date.
- Price efficiency: The narrow price range (spanning 30 pence) reflects strong market confidence and indicates that the Company’s management believes the shares are undervalued at the current level.
- Regulatory compliance: All buy‑back transactions were conducted in line with the UK FCA’s Market Abuse Regulation (MAR) and the LSE’s statutory requirements for open‑market share repurchases.
Strategic Rationale The Company’s buy‑back serves multiple objectives: (1) enhancing earnings per share (EPS) through dilution management, (2) signalling management confidence in the company’s valuation, and (3) providing liquidity for shareholders. The modest price movement suggests that the program is unlikely to create significant short‑term volatility.
3. Repurchase on the CBOE Europe Venue
| Date | Venue | Price (USD) | Shares Purchased | Program Status |
|---|---|---|---|---|
| 22 Sep 2026 | CBOE Europe | $12.48 | 1.8 M | 7.4 % of program |
- Market conditions: The repurchase price of $12.48 reflects a 0.8 % increase from the program’s initial offer price of $12.35, indicating a modest upside in the company’s valuation.
- Execution mechanics: Shares were bought in a block trade executed at the midpoint of the quoted spread, thereby minimizing market impact.
- Compliance framework: The transaction adhered to the European Securities and Markets Authority (ESMA) disclosure obligations for significant share repurchases and the CBOE Europe trading rules.
Investor Takeaway The additional repurchase on CBOE Europe augments the overall buy‑back momentum and underscores the Company’s unified approach across all trading venues. The incremental nature of the program suggests a disciplined strategy, avoiding over‑exposure to market timing risk.
4. Regulatory and Market Impact Analysis
| Regulatory Body | Key Requirement | Company Action | Impact Assessment |
|---|---|---|---|
| FCA (UK) | MAR disclosure | Daily buy‑back reporting | Maintains market integrity, minimal impact on liquidity |
| ESMA | Significant Shareholding Disclosure | Aggregate repurchase reporting | Transparent to EU investors, aligns with cross‑border oversight |
| LSE & CBOE Europe | Trade Reporting | Real‑time transaction logs | Enables market participants to monitor supply–demand dynamics |
- Liquidity Considerations: The combined volume of 7.1 M shares repurchased across both venues represents 0.3 % of the Company’s 2.35 B outstanding shares, indicating a negligible immediate effect on market depth.
- Price Stability: Historical data suggests that share repurchases of less than 1 % of total outstanding shares typically exert limited price pressure; the narrow price ranges observed support this expectation.
- Investor Confidence: Consistent repurchase activity signals a commitment to shareholder value, often correlated with higher stock valuations in equity markets.
5. Actionable Insights for Stakeholders
| Stakeholder | Recommended Action |
|---|---|
| Institutional Investors | Reassess portfolio weightings in light of the ongoing buy‑back; consider increased exposure if valuation fundamentals remain attractive. |
| Portfolio Managers | Monitor cumulative repurchase totals to gauge potential EPS enhancement; adjust risk models accordingly. |
| Corporate Boards | Evaluate program pacing relative to cash‑flow projections and capital‑deployment plans; maintain clear communication with regulators to preempt any compliance gaps. |
| Traders & Market Makers | Anticipate minimal volatility; incorporate repurchase data into short‑term pricing models. |
| Regulators | Continue to monitor adherence to disclosure obligations; assess whether the pace of repurchases aligns with broader market‑stability objectives. |
6. Conclusion
The 22 September 2026 regulatory disclosures demonstrate CBOE Global Markets’ disciplined approach to capital management and asset‑management operations. The continued growth in NAVs across iShares ETFs, coupled with structured share‑repurchase activity on both the LSE and CBOE Europe, reflects a strategy that balances shareholder returns with regulatory compliance. For market participants, these developments provide a clear signal of management confidence and an opportunity to calibrate investment decisions in a manner that is consistent with prevailing market dynamics and regulatory frameworks.
